# Azora Therapeutics, Inc. (DE): Form 8-K, filed May 11, 2026

- Company: [Azora Therapeutics, Inc. (DE)](/companies/adil.md) (CIK 1513525)
- Form: 8-K
- Filed: 2026-05-11
- Accepted by EDGAR: May 11, 2026, 08:40 ET
- Period: 2026-05-11
- Accession: 0001213900-26-054219
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1513525/000121390026054219/ea0289947-8k_adialpharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1513525/000121390026054219/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1513525/000121390026054219/ea0289947-8k_adialpharma.htm

Filed May 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-054219. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
